GIPR activation potentiates insulin secretion, may improve fat distribution, and enhances central appetite regulation through mechanisms complementary to GLP-1R signaling
Diabetes indications are often treated differently from obesity indications
-Cell is vulnerable to reactive oxygen species (ROS) 7,8
What to Expect During Treatment Setting realistic expectations helps you evaluate progress and make informed decisions about continuing or adjusting treatment
PlexusDx serves all 50 states, requires no insurance, and is HSA/FSA eligible, making it accessible for patients building a personalized GLP-1 schedule
Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens